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Abstract
Background: In Tunisia, Cardiovascular Diseases are the leading causes of death (30%), 70% of those are coronary heart
disease (CHD) deaths and population studies have demonstrated that major risk factor levels are increasing.
Objective: To explain recent CHD trends in Tunisia between 1997 and 2009.
Methods: Data Sources: Published and unpublished data were identified by extensive searches, complemented with
specifically designed surveys.
Analysis: Data were integrated and analyzed using the previously validated IMPACT CHD policy model. Data items included:
(i)number of CHD patients in specific groups (including acute coronary syndromes, congestive heart failure and chronic
angina)(ii) uptake of specific medical and surgical treatments, and(iii) population trends in major cardiovascular risk factors
(smoking, total cholesterol, systolic blood pressure (SBP), body mass index (BMI), diabetes and physical inactivity).
Results: CHD mortality rates increased by 11.8% for men and 23.8% for women, resulting in 680 additional CHD deaths in
2009 compared with the 1997 baseline, after adjusting for population change. Almost all (98%) of this rise was explained by
risk factor increases, though men and women differed. A large rise in total cholesterol level in men (0.73 mmol/L) generated
440 additional deaths. In women, a fall (20.43 mmol/L), apparently avoided about 95 deaths. For SBP a rise in men
(4 mmHg) generated 270 additional deaths. In women, a 2 mmHg fall avoided 65 deaths. BMI and diabetes increased
substantially resulting respectively in 105 and 75 additional deaths. Increased treatment uptake prevented about 450
deaths in 2009. The most important contributions came from secondary prevention following Acute Myocardial Infarction
(AMI) (95 fewer deaths), initial AMI treatments (90), antihypertensive medications (80) and unstable angina (75).
Conclusions: Recent trends in CHD mortality mainly reflected increases in major modifiable risk factors, notably SBP and
cholesterol, BMI and diabetes. Current prevention strategies are mainly focused on treatments but should become more
comprehensive.
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Introduction
The Eastern Mediterranean Region (EMR) has been recog-
nized as a growing hot spot for Cardiovascular Diseases (CVD)
and type2 diabetes. Projections of the growing burden exceed
those of most other regions. About 47% of the region’s current
burden of disease is due to non-communicable diseases (NCDs),
and the Global Burden of Disease project have estimated that this
proportion will rise to about 60% by the year 2020 [1]. Rates of
coronary heart disease (CHD) will have increased by 160% in the
region of Middle East and North Africa [2]. Meanwhile, mortality
due to NCDs is decreasing in the developed world, namely,
Western Europe, North America and Australia/New Zealand.
This decline is driven largely by improved public health and
medical access for a greater proportion of the population.
Tunisia is a Northern African country, located between Algeria
and Libya, with a population of about ten million. It is typical
amongst emerging South and East Mediterranean countries,
having recently undergone a rapid economic development and is
currently ranked 98th out of 177 on the Human Development
Index composite scale in 2009 [3].
Tunisia has experienced a crucial demographic transition,
reflecting a sustained and integrated economical, social and health
PLOS ONE | www.plosone.org 1 May 2013 | Volume 8 | Issue 5 | e63202
development. The global fertility rate is about 2 and the
population is still young, with 24% under 15 years. However the
population aged over 65 years is rapidly increasing, already
exceeding 6% [4].Now, Tunisia is facing a rapidly growing burden
of NCDs and CVDs are the leading causes of death accounting for
almost 30%, 70% of those are CHD death [5,6].
The epidemiological transition has been compounded by
powerful environmental and behavioral changes. In particular,
the adoption of new dietary habits and sedentary lifestyles, and the
stress of urbanization and of working conditions may all lead to
increases in major cardiovascular disease (CVDs) risk factors and
mortality. Trends in conventional cardiovascular risk factors are
well documented in Tunisia. Levels are dramatically high,
especially in the coastal area [5,7,8]. In the meanwhile, health
services, developed to tackle acute infectious diseases, appear to be
unable to cope with the epidemiological situation and with the
rises of the non-communicable diseases (NCDs).
This study aims to explain the substantial increase in CHD
mortality between 1997 and 2009 in Tunisia, in order to inform
future policy scenarios.
Methods
The IMPACT model was previously validated in many
developed countries with declining CHD trends and in China,
where CHD trends increased [9].
The model is used to explore trends in the Middle East and
specifically in Tunisia between 1997 and 2009.
Data on risk factor levels and current uptake levels of evidence
based treatments were identified by extensive searches for
published and unpublished data and complemented with specif-
ically designed surveys. All data sources are detailed in Appendix
S1 in File S1. The data required for the analysis was generally
available for men and women aged over than 25 years in Tunisia
for the period 1997–2009 with some exceptions amongst the oldest
age groups (75 years and older). Data items used to populate the
model included: (i) Patient numbers in specific CHD groups
(including Myocardial Infarction Congestive Heart Failure, and
Chronic Angina Pectoris, (ii) uptake of specific medical and
surgical treatments, and (iii) population trends in major cardio-
vascular risk factors (smoking, total cholesterol, systolic blood
pressure, body mass index, diabetes and physical inactivity).The
main output of the model between 1997 and 2007 is the number
of deaths prevented or postponed (DPPs) attributed to the change
in treatment or risk factors level.
Identification and Assessment of Relevant Data
Validated information on the Tunisian population demo-
graphic changes was obtained from Tunisian National Institute
of Statistics for 1997 and 2009 [10,4].
The numbers of deaths for both years were obtained
from the National Public Health Institute - Tunisian Ministry of
Public Health. CHD deaths are coded according to the 10th
revision of International Classification of Diseases (ICD10), using
the STIX software [4,6,10,11].
Population risk factors trend data for 1997 and 2009
were obtained from national and regional epidemiological studies
conducted in the community. The surveys were cross-sectional
and the target population based on a nationally representative,
stratified cluster sample of households according to the seven
administrative regions of Tunisia and included both urban (65.9%)
and rural areas (34.1% ) [7,12–15].
The numbers of hospital admissions with CHD in
addition to treatment uptake were obtained from the
Tunisian Epidemiological Study ‘‘TEPS-ACS 2009’’ conducted
in 2009 during the MedCHAMPS Project which included 5 of the
most important Tunisian hospitals [16].
Data concerning secondary prevention was obtained from
Premise I (Prevention of recurrence of Myocardial Infarction and
Stroke) conducted by the Cardiovascular Epidemiology and
Prevention Research Laboratory in 2002 and Premise II
conducted in 2009 during the MedCHAMPS Project [17].
The number of patients undergoing Coronary Artery Bypass
Grafting (CABG) and Angioplasty were obtained from the
National Health Insurance Fund. The prevalence of Angina,
Heart Attack survivors and Congestive Heart Failure in the
community were estimated based on national health surveys and
treatment uptake survey conducted by the Cardiovascular
Epidemiology and Prevention Research Laboratory. We have
access to the raw data for all these studies. Data on treatment
uptake in the community was supported by systematically eliciting
expert opinion.
Efficacy of Therapeutic Interventions
We used recent meta-analyses and large randomised controlled
trials. The Mant and Hicks approach was used to correct for
polypharmacy. This approach consists to compare the relative
sensitivity of measures of process and outcome to differences in
quality of care or the hospital treatment of myocardial infarction
basing on meta-analysis and large randomised controlled trials to
estimate the impact that optimal use of these interventions would
have on mortality in a typical district general hospital. [18].
The Change in Coronary Heart Disease Deaths
First, the number of CHD deaths expected in 2009 was
calculated by indirect age standardization assuming that 1997
mortality rates had persisted unchanged until 2009. The number
of CHD deaths actually observed in 2009 was then subtracted.
The difference between the two represents the rise or fall in
coronary heart disease deaths (the number of deaths prevented or
postponed) that the IMPACT model needed to explain.
The Mortality Changes Attributed to Risk Factor Trends
The number of deaths prevented or postponed from changes in
risk factors was estimated using two approaches. The regression b
coefficients approach was used to quantify the population
mortality impact of changes in those specific risk factors, measured
as continuous variables, (systolic blood pressure, total cholesterol
and body mass index - BMI). The second approach, population
attributable risk fraction, was employed for categorical variables-
diabetes, physical inactivity and smoking using Levin’s formula:
PAR~
Pr evalence  RelativeRisk{1ð Þ
Pr evalence  (RelativeRisk{1)z1ð Þ :
Details of the IMPACT model methodology have been
published previously [19] and are detailed in appendix S2 in File
S1.
Estimating the Contribution of Medical and Surgical
Treatments
The model aimed to include all medical and surgical treatments
in 1997 (the base year) and 2009 (the final year). Treatment uptake
data was not available for the year 1997 and was therefore
estimated after consultation with cardiologists and experts working
in both hospital and community at that time.
Coronary Heart Disease Mortality
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The mortality reduction for each treatment for the number of
patients in each group, stratified by age and sex, was calculated as
the relative mortality reduction reported in published meta-
analyses multiplied by both; the age-specific case fatality observed
in that group and the patient uptake (the proportion receiving that
specific treatment (Appendix S1 in File S1). Survival benefit over a
one-year time interval was used for all treatments.
Treatment Adherence and Overlaps
Potential overlaps between different groups of patients were
identified and appropriate adjustments were then made. Patient
group calculations and assumptions are detailed in Appendix S2 in
File S1.
Adherence (defined as the proportion of treated patients actually
taking therapeutically effective levels of the prescribed medication)
was assumed to be 100% among hospital patients, 70% among all
symptomatic community patients, and 50% among asymptomatic
community patients, based on the literature and expert opinion.
Model Validation: Comparison with Observed Mortality
Falls
The model estimate for the changes in deaths attributed to all
treatments plus all risk factor changes was summed for men and
women in each specific age group and then the model fit was
compared with the observed change in mortality for that group.
Sensitivity Analyses
Because of the uncertainties surrounding some of the values,
multi-way sensitivity analyses using the Brigg’s analysis of extremes
method was used [20].
Results
Tunisia has approximately 10 million inhabitants: The popu-
lation has grown from 9,211,000 in 1997 to10, 458,000 in 2009.
We investigated the population aged over 25 years. For this age
group, the number of men grew from 2,125,000 in 1997 to 2,
789,0000 in 2009 and from 2,142,000 to 2,910,000 for women.
In Tunisia, recent trends in coronary heart disease (CHD)
mortality were complex.
The rise in age specific CHD mortality among women was
twice as large as the observed among men aged over than 25 years
between 1997 and 2009. It increased by 11.8% in men (from 70 to
87 per 100 000) and by 23.8% in women (from 28 to 41 per 100
000).The rise in mortality was observed primarily in men aged 55+
and women 65+, while younger men and women showed a decline
of 5% (men 25–54) and 7% (women 45–64) (Table 1).
This resulted in 680 additional CHD deaths in 2009 compared
with the number expected if 1997 mortality rates had persisted.
Risk Factor Changes between 1997 and 2009 (Figure 1)
Changes in major cardiovascular risk factors together produced
a best estimate of 665 more deaths (minimum estimate 354,
maximum 905) (Table 2). The foremost contribution came from
the rise in total cholesterol levels leading to an estimated 340
additional deaths (minimum 160, maximum 430). A large rise in
men (0,73 mmol/L), generated approximately 440 additional
deaths. However in women, a fall (20,43 mmol/L), apparently
avoided some 95 deaths. The increase in systolic blood pressure
generated 270 additional deaths (minimum 125, maximum 295) in
men reflecting a large rise (4 mmHg). In women, a fall (2 mmHg),
resulted in approximately 65 fewer deaths. Increased mean BMI
increased substantially in men (2 Kg/m2) causing 85 and in
women (1 Kg/m2) causing 20 additional deaths. Diabetes
prevalence increased from 12% to 17% between 1997 and 2009
resulting approximately 75 additional deaths (minimum approx-
imately 50, maximum 110) respectively 65 and 10 in men and
women. Favorable trends in physical inactivity and smoking
prevented or postponed approximately 45 (minimum 25, maxi-
mum 65) deaths. Self-reported physical inactivity decreased from
98.4% to 85, 2% in between 1997 and 2009. This generated
approximately 35 fewer deaths in men and 10 fewer in women.
Smoking changes prevented approximately 15 (minimum 10,
maximum 25) CHD deaths overall. A decrease in smoking resulted
in some 55 fewer deaths in men, but 40 additional deaths in
women were statistically attributed to a rise in smoking (Table 2).
Medical and Surgical Treatments (Figure 1)
The model approximately estimated that 450 (minimum 180,
maximum 1565) CHD deaths were prevented or postponed by
medical and surgical treatments between 1997 and 2009. The
biggest contributions came from secondary prevention following
Acute Myocardial Infarction (95, (minimum 30, maximum 225),
with ACE inhibitors, Beta blockers, statins, warfarin and aspirin
being the main contributors in this group. Initial treatments for
AMI explained approximately 90 (minimum 50, maximum 220)
deaths prevented or postponed. Antihypertensive medications,
treatments for unstable angina, as well as heart failure in the
community and in hospital have contributed to a larger proportion
of the mortality reductions; respectively estimated as 80 (minimum
10, maximum 450), 75 (minimum 35, maximum 175), 50
(minimum 15, maximum 115) and 35(minimum 10, maximum
85). Smaller contributions to DPPs were estimated from secondary
prevention post angioplasty 5 deaths (minimum 1, maximum 10)
(Table 3).
Validation and Model Fit
In summary, when including risk factors and treatment data, the
model explained approximately 45% of the total mortality increase
in the Tunisian population between 1997 and 2009. The
remaining percent was unexplained and might reflect data quality
issues or changes in other, unmeasured risk factors. The model
estimates of deaths were generally consistent with the observed
deaths for almost all age groups. The exception was in the age
groups 45–54 and 55–64 years where a higher number of deaths
were expected for both men and women. Overall, the model fit
was better for women than for men (Table 4).
Sensitivity Analyses (Figures 2 and 3)
Moreover, irrespective of whether best minimum or maximum
estimates were used, the relative contributions remained relatively
consistent (Figure 2 and 3). The largest part of the mortality
increase was explained by large rises in total cholesterol levels,
blood pressure, BMI and diabetes (Figure 2). Likewise, the
principal mortality reductions from treatments consistently came
from therapies for acute coronary syndromes, secondary preven-
tion, heart failure and hypertension (Figure 3).
Discussion
Coronary heart disease mortality increased by 17% in Tunisia
between 1997 and 2009. Similar mortality rises have recently been
observed in many other middle income countries [9,21].
Almost all of this CHD mortality increase in Tunisia was
explained by rises in major risk factors. With increased levels of
development, come increased risk factors levels as well as
improvements in uptake treatments. In fact, without improve-
Coronary Heart Disease Mortality
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Figure 1. CHD Mortality Trends in Tunisia 1997–2009: additional deaths attributable to risk factor changes & deaths prevented or
postponed by treatments.
doi:10.1371/journal.pone.0063202.g001
Table 1. Population sizes and death rates of CHD in Tunisia, 1997 and 2009.
Gendre Age group Population (1000) Death (number) Death rates per 100,000 % Change
1997 2009 1997 2009 1997 2009 (Crude) (Weighted by pop)
Men 25–34 733 866 10 11 1 1 211.1% 23.5%
35–44 549 670 34 82 6 12 100.3% 24.1%
45–54 318 571 215 261 68 46 232.2% 26.6%
55–64 261 330 334 426 128 129 0.9% 0.1%
65–74 174 216 454 645 260 299 14.8% 1.1%
75–84 61 95 333 713 543 753 38.7% 1.3%
.=85 29 41 112 290 387 702 81.4% 1.2%
Subtotal 2126 2789 1492 2429 70 87 24.0% 11.8%
Women 25–34 751 908 0 3 0 0
35–44 546 723 12 29 2 4 85.0% 21.1%
45–54 329 574 55 52 17 9 246.0% 29.1%
55–64 264 348 118 91 45 26 241.3% 24.9%
65–74 201 227 194 271 96 119 24.2% 1.9%
75–84 57 92 175 464 309 502 62.8% 2.0%
.=85 28 39 60 294 215 757 252.9% 3.4%
Subtotal 2176 2911 614 1205 28 41 46.6% 23.8%
Total 4301 5700 2106 3633 49 64 30.2%
doi:10.1371/journal.pone.0063202.t001
Coronary Heart Disease Mortality
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ments in treatments, the death rates would have been even
higher.
Cholesterol, Blood Pressure, Diet and Physical Activity
The biggest CHD mortality contribution came from the rises in
total cholesterol and systolic blood pressure levels, but only among
men. These differing gender trends can be partly explained by
some dietary characteristics, such as fat and salt intakes which
were significantly higher in men in the nutritional survey [13].
Rises in total cholesterol and systolic blood pressure levels
generally reflect prominent lifestyle changes. As most developing
countries, Tunisia has experienced a ‘‘hyper urbanization’’ that
has improved health coverage, but has also introduced new
lifestyles, such as sedentary habits and westernized diet [5]
Nationally, the proportion of animal’s protein among the total
protein intake has almost doubled during the last 3 decades (14%
in 1975 to 27% in 2005) [22]. In fact, compared with rural areas
Tunisian people in urban areas consume almost twice as much
meat (42 Kg/person/year vs. 26 Kg/person/year) and milk
(63 Kg/person/year vs. 38 Kg/person/year). Conversely, wheat
consumption is almost 3 times higher in rural areas
(129 vs.55 Kg/person/year).
A large meta-analysis estimated that a long term reduction in
cholesterol concentration of 10%, which can be achieved by
moderate dietary change, lowers the risk of ischemic heart disease
by 30% at age of 60 years. The full benefits are achieved by 5
years [23]. Healthy diet therefore currently represents a missed
opportunity for health promotion policies in Tunisia.
Increasing physical activity levels play a potentially important
position in reducing cardiovascular risk factors [24]. However, a
recent study conducted in an urban area of Tunis showed that
more than the half of the population has low levels of physical
activity [8].
Surprisingly, available Tunisian data used in the model showed
an apparent improvement in physical activity between 1997 and
2009, possibly gaining 45 DPPs. However these results must be
interpreted with caution, because different definitions of physical
activity were used in two studies.
Increased urbanization normally results in several environmen-
tal factors which may discourage participation in physical activity
such as: violence, high density traffic, low air quality, pollution and
lack of parks, sidewalks and sport/recreation facilities [25].
Overweight, Obesity and Diabetes
Between 1997 and 2007, BMI increased by an average of 2 kg/
m2 in men and 1 kg/m2 in women and caused over 100 additional
CHD deaths. The abdominal obesity prevalence increased in men
by 74% and 68% in women between 1997 and 2009. These might
explain the discrepancy between the trends in cholesterol and
systolic blood pressure in men compared to women. Furthermore,
diabetes prevalence, increased from 12% to 17% between 1997
and 2009, this dramatic rise generated approximately 75
additional deaths. One Tunisian national study showed that
diabetes prevalence is significantly and independently related to
both urban residency and high BMI [26].
The rise in both BMI and Diabetes was responsible for
approximately 26% of the increase in CHD deaths. This
represents a public health priority. Effective evidence-based
interventions exist such as junk-food taxing [27,28] and should
be urgently considered.
The recently published Tunisian formed non-communicable
diseases (NCD) strategy adopted an integrated approach and
Table 2. Deaths attributable to population risk factor changes in Tunisia 1997–2009.
RISK FACTORS Risk factor level Risk factor change
Deaths prevented or
postponed (DPPs) % of Total mortality change
1997 2009 Absolute Relative Best Min Max
SMOKING (Total): % 23.9% 22.7% 0.01 20.05 15 10 25 2.2%
Men 47.2% 41.9% 0.05 55
Women 1.5% 4.3% 20.03 240
SYSTOLIC BLOOD PRESSURE (Total):
mm/HG
130.41 131.03 20.62 0.00 2205 2125 2295 230.8%
Men 129.45 133.42 23.97 2270
Women 131.33 128.75 2.59 65
CHOLESTEROL (Total): mmol/l 4.59 4.73 20.14 20.04 2340 2160 2430 251.1%
Men 4.44 5.17 20.73 2440
Women 4.73 4.31 0.43 100
PHYSICAL INACTIVITY(Total): % 98.44% 85.16% 0.13 20.13 45 30 65 6.7%
Men 97.29% 81.62% 0.16 35
Women 99.53% 88.54% 0.11 10
BMI (Total):Kg/m2 26.03 27.47 21.45 0.06 2105 60 160 215.8%
Men 24.83 26.76 21.94 285
Women 27.17 28.15 20.98 220
DIABETES (Total): % 12.09% 17.26% 20.05 0.43 275 50 110 211.2%
Men 11.99% 18.89% 265
Women 12.20% 15.70% 210
Estimated total risk factor effects 2665 2135 2770 297.8%
doi:10.1371/journal.pone.0063202.t002
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Table 3. Deaths prevented or postponed by medical & surgical treatments in TUNISIA in 2009.
Treatmentuptake Best DPPs Min DPPs Max DPPs
INITIAL TREATMENTS FOR ACUTE MI 90 50 220
Community CPR 5,0% 0 0 1
Hospital CPR 50,0% 12 8 21
Thrombolysis 20,4% 13 5 25
Aspirin 94,8% 46 19 84
Beta blockers 67,8% 8 3 16
ACE inhibitor 71,6% 16 7 33
PTCA (STEMI) 43,2% 41 17 85
CABG 4,0% 2 1 5
Cardiac rehabilitation 0,0% 0 0 0
UNSTABLE ANGINA 75 35 175
Aspirin&heparin 66,1% 59 24 123
Aspirin 29,0% 16 7 32
PG IIA/IIIB 1,1% 0 0 1
CABG surgery 4,2% 5 2 11
PTCA 5,0% 5 2 10
SECONDARY PREVENTION FOLLOWING AMI 95 30 225
Aspirin 91,9% 95 31 224
Beta blockers 45,7% 40 13 90
ACE inhibitors 54,0% 39 13 98
Statins 53,6% 39 13 97
Warfarin 0,0% 44 14 109
Rehabilitation including exercise 5,4% 0 0 0
SECONDARY PREVENTION FOLLOWING CABG OR PTCA 5 1 10
Aspirin 94,8% 2 1 4
Beta blockers 39,1% 1 0 3
ACE inhibitors 48,9% 1 0 3
Statins 72,0% 2 1 5
Warfarin 0,9% 0 0 0
Rehabilitation 0,0% 0 0 0
HEART FAILURE IN THE HOSPITAL 35 10 90
ACE inhibitors 20,0% 10 3 30
Beta blockers 50,0% 44 12 131
Spironolactone 25,0% 25 8 62
Aspirin 95,0% 48 16 104
Statins 0,0% 0 0 0
HEART FAILURE IN THE COMMUNITY 50 15 115
ACE inhibitor 10,0% 14 4 42
Beta blockers 21,7% 67 22 167
Spironolactone 7,1% 19 6 48
Aspirin 49,0% 71 23 172
Statins 21,8% 0 0 0
STATINS FOR PRIMARY PREVENTION 20 5 210
ANTIHYPERTENSIVE MEDICATION 80 12 451
TOTAL TREATMENT EFFECTS IN 2009 1170 365 3515
TOTAL TREATMENT EFFECTS IN 1997 720 225 2150
INCREASE IN TREATMENT EFFECTS BETWEEN 1997 AND 2009 450 180 1565
doi:10.1371/journal.pone.0063202.t003
Coronary Heart Disease Mortality
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encompassed promotion, prevention and control NCD strategies.
To control diabetes and promote physical activity population
based multi-sectorial effective evidence-based interventions were
clearly indicated such as health promotion, fiscal measures, market
control and community participation. However a clear vision and
scope of implementation is still evolving [29].
Table 4. Model validation: estimated versus observed changes in CHD deaths in Tunisia between 1997 and 2009.
OBSERVED CHANGE 1997–2009 MODEL ESTIMATES Discrepancy Model FIT
M 25–34 21 1 22 2100%
M 35–44 249 241 27 84%
M 45–54 247 124 2171 2265%
M 55–64 292 24 288 4%
M 65–74 2191 282 2107 43%
M 75–84 2380 2198 2181 52%
M 85+ 2178 2130 248 73%
Total Men 2936 2330 2604 35%
F 25–34 23 23 0 100%
F 35–44 217 214 24 82%
F 45–54 3 45 241 1500%
F 55–64 27 64 238 237%
F 65–74 277 253 225 68%
F 75–84 2289 2179 2110 62%
F 85+ 2234 2211 223 90%
Total women 2591 2350 2241 60%
Total
Men & Women
21527 2680 2845 45%
doi:10.1371/journal.pone.0063202.t004
Figure 2. Proportional contributions of specific risk factor changes to trends in CHD deaths number in Tunisia 1997–2009-
sensitivity analysis.
doi:10.1371/journal.pone.0063202.g002
Coronary Heart Disease Mortality
PLOS ONE | www.plosone.org 7 May 2013 | Volume 8 | Issue 5 | e63202
Smoking
Interestingly, a slight fall in smoking among men resulted in
some 55 fewer deaths. Studies conducted over the last 20 years
show that the tobacco epidemic in Tunisia is firmly established
especially among men [30]. However since 1992 anti-smoking
measures started by campaigns of information, enactment of an
anti-smoking law, has resulted in a decrease in tobacco sales being
observed [31]. Recently in 2010, Tunisia adopted WHO
Framework Convention on Tobacco Control, and a strategy was
implemented in 2009, with clear goals, and some encouraging
results for 2010 [32]. However, the proportion of young and
increase in female smokers remains alarming. The consequences
of tobacco addiction in Tunisia, in term of prevalence and
mortality, will thus be even heavier in the next two decades [31].
Cardiological Treatments
Modern medical treatments prevented or postponed approxi-
mately 445 CHD deaths. The biggest contributions came from
treatments delivered in the community for secondary prevention,
hypertension and heart failure plus therapies for acute coronary
syndromes. The effect of treatment on CHD mortality reduction
are thus broadly similar to that reported for Iceland, Sweden and
Finland [33] but lower than that reported for North America [34]
and Europe [35,36] in studies using the same methodology.
Despite well established benefits, pharmacological agents
continue to be underutilized in Tunisia. As reported by the
WHO-PREMISE study, only 6% of eligible CHD patients were
receiving statins in 2002 [37]. Also, non compliance rates are
alarming, with 63% hypertensive patients not continuing with
drug therapies [38,39].
A UK study suggested that improvements in uptake could make
a large impact on the reduction of CHD mortality, which
suggested that DPP by current treatments would be double if the
uptake levels increase to 80% [40]. Likewise the benefits of
medical treatments in Tunisia could be optimized if treatment
uptake were improved. However, such policy creates multiple
challenges for health providers in term of identifying patients,
providing medications and ensuring their long-term compliance.
Data on both patients groups and treatment uptake levels was
scarce. The required information in this study was collected
directly from the medical-patients records. This revealed some
gaps in the NCD health information system. Furthermore
treatment uptake levels were not consistent among different
hospitals and sometimes physicians, which highlight a lack of
standardized health care provision.
Modeling Strengths and Limitations
The modeling approach used in the study synthesized all the key
risk factors and treatment options to help quantify changes in
CHD mortality. It usefully provided estimates of the effectiveness
and cost-effectiveness for each factor considered [41]. Addition-
ally, the model assessed the potential maximum and minimum
Figure 3. Proportional contributions of specific treatments to trends in CHD deaths number in Tunisia 1997–2009- sensitivity
analysis.
doi:10.1371/journal.pone.0063202.g003
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plausible effects of these factors using rigorous sensitivity analyses
these examined systematically the influence of uncertainties in the
assumptions used in the studies.
This modeling approach also has obvious limitations.
Notably here the extent and quantity of available data on CHD
risk factor trends and treatment uptake. However, in general the
data used in this model were of good quality. Mortality data were
obtained from Ministry of Health death registry [4,10]. Death
registry data was evaluated in previous studies as medium quality
based on the WHO criteria. The demographic information was
obtained from the censuses data and the risk factor trends were
obtained from well designed epidemiological studies and surveys
using the WHO STEPS methodology. Treatment uptake and
patients groups data were obtained from an extensive hospital
based survey conducted in 2009. Data was scarce on treatment
uptake. Certain assumptions were needed to fill in the gaps for
missing information.
Public Health Implications
CHD mortality rose by 30 percent between 1997 and 2009 in
Tunisia. Almost all of this rise was attributable to increases in
major risk factors especially total cholesterol, blood pressure,
obesity and diabetes. The prevalence of those risks is high in both
men and women and are a concern for both the urban and rural
populations. Most hypertensives were not aware of their BP, the
treatment rate was low and control of hypertension was poor even
on treatment. Our results clearly indicate that risk factors changes
currently generate many avoidable CHD deaths.
Conversely, improvements in risk factors in the general
population could save many more lives compared to treatments
for individual patients. This emphasizes the importance of primary
prevention CHD strategies: evidence-based policies which would
benefit the whole population.
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